Comparative Evaluation of L-Fd4C and Related Nucleoside Analogs as Promising Antiviral Agents

Shu-Hui      Chen

Abstract

As documented in the recent literature, there are more than 50 million people infected with HIV worldwide to date since the emergence of HIV and AIDS in the Western world in 1981. More importantly, about 7000 people die of AIDS daily with 2.5 and 2.6 millions total deaths in 1998 and 1999, respectively. On the other hand, human hepatitis B virus (HBV) is the leading cause of chronic hepatitis in the world. According to

Keywords: antiviral agents, nucleosides, anti-hbv agents, oxetanocins, acyclic nucleosides, oxetanocin, cyclobut, acyclovir

Rights & Permissions Print Cite

Current Medicinal Chemistry

Title: Comparative Evaluation of L-Fd4C and Related Nucleoside Analogs as Promising Antiviral Agents

Volume: 9 Issue: 9

Author(s): Shu-Hui Chen

Affiliation:

Keywords: antiviral agents, nucleosides, anti-hbv agents, oxetanocins, acyclic nucleosides, oxetanocin, cyclobut, acyclovir

Abstract: As documented in the recent literature, there are more than 50 million people infected with HIV worldwide to date since the emergence of HIV and AIDS in the Western world in 1981. More importantly, about 7000 people die of AIDS daily with 2.5 and 2.6 millions total deaths in 1998 and 1999, respectively. On the other hand, human hepatitis B virus (HBV) is the leading cause of chronic hepatitis in the world. According to

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Chen Shu-Hui, Comparative Evaluation of L-Fd4C and Related Nucleoside Analogs as Promising Antiviral Agents, Current Medicinal Chemistry 2002; 9 (9) . https://dx.doi.org/10.2174/0929867024606696

DOI https://dx.doi.org/10.2174/0929867024606696	Print ISSN 0929-8673
Publisher Name Bentham Science Publisher	Online ISSN 1875-533X

About this journal

Call for Papers in Thematic Issues

Submission closes on : 08 September, 2024

Advances in Medicinal Chemistry: From Cancer to Chronic Diseases.

The broad spectrum of the issue will provide a comprehensive overview of emerging trends, novel therapeutic interventions, and translational insights that impact modern medicine. The primary focus will be diseases of global concern, including cancer, chronic pain, metabolic disorders, and autoimmune conditions, providing a broad overview of the advancements in ...read more

Guest Editor(s): Geir Bj?rklund

Submission closes on : 08 July, 2024

Cellular and Molecular Mechanisms of Non-Infectious Inflammatory Diseases: Focus on Clinical Implications

The Special Issue covers the results of the studies on cellular and molecular mechanisms of non-infectious inflammatory diseases, in particular, autoimmune rheumatic diseases, atherosclerotic cardiovascular disease and other age-related disorders such as type II diabetes, cancer, neurodegenerative disorders, etc. Review and research articles as well as methodology papers that summarize ...read more

Guest Editor(s): Igor A. Sobenin

Submission closes on : 14 July, 2024

Chalcogen-modified nucleic acid analogues

Chalcogen-modified nucleosides, nucleotides and oligonucleotides have been of great interest to scientific research for many years. The replacement of oxygen in the nucleobase, sugar or phosphate backbone by chalcogen atoms (sulfur, selenium, tellurium) gives these biomolecules unique properties resulting from their altered physical and chemical properties. The continuing interest in ...read more

Guest Editor(s): Katarzyna Kulik

Submission closes on : 03 June, 2024

Current advances in inherited cardiomyopathy

Describe in detail all novel advances in multimodality imaging related to inherited cardiomyopathy diagnosis and prognosis. Shed light to deeper phenotypic characterization. Acknowledge recent advances in genetics, genomics and precision medicineread more

Guest Editor(s): Emmanuel S. Androulakis